October 23, 2017 SAN LUIS OBISPO, Calif.–(BUSINESS WIRE)–FzioMed, Inc., a biomaterials company celebrating 21 years in business, has received approval from FDA to conduct a small confirmatory study of Oxiplex® in the United States. Oxiplex® is an absorbable, synthetic viscoelastic gel that is applied following partial discectomy, with the intent […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone